23 November 2017
News and Views
Links and Services
February's issue of the Inflammatory Bowel Diseases investigates whether a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.
The medical treatment for inflammatory bowel disease (IBD) has improved over the past 20 years. <
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors